The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
暂无分享,去创建一个
Takao Shimizu | Charles N. Serhan | G. Enrico Rovati | Takehiko Yokomizo | J. Drazen | S. Dahlén | Takao Shimizu | C. Serhan | N. Chiang | T. Yokomizo | C. Brink | Jeffrey M. Drazen | G. Rovati | Sven-Erik Dahlén | D. Hay | Nan Chiang | Charles Brink | Douglas W. P. Hay | Chia Nan
[1] Charles N. Serhan,et al. Molecular circuits of resolution: formation and actions of resolvins and protectins , 2005, The Journal of Immunology.
[2] C. Serhan,et al. Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.
[3] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[4] T. Kenakin,et al. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. , 1997, Trends in pharmacological sciences.
[5] N. Maheshwari,et al. A Role for the Mouse 12/15-Lipoxygenase Pathway in Promoting Epithelial Wound Healing and Host Defense* , 2005, Journal of Biological Chemistry.
[6] M. Perretti,et al. Modulation of Phagocytosis of Apoptotic Neutrophils by Supernatant from Dexamethasone-Treated Macrophages and Annexin-Derived Peptide Ac2–261 , 2005, The Journal of Immunology.
[7] J. Cornhill,et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.
[8] B. Levy,et al. Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury1 , 2005, The Journal of Immunology.
[9] Jilly F. Evans,et al. International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors , 2003, Pharmacological Reviews.
[10] M. Perretti,et al. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. , 2006, Blood.
[11] P. Ridker,et al. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] T. Mayadas,et al. Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. , 1996, Kidney international.
[13] Terry Kenakin,et al. Efficacy at g-protein-coupled receptors , 2002, Nature Reviews Drug Discovery.
[14] C. Clish,et al. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. , 1998, The Journal of pharmacology and experimental therapeutics.
[15] E. Pamer,et al. Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins , 1994, The Journal of experimental medicine.
[16] K. Sugamura,et al. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.
[17] V. Arroyo,et al. Aspirin (ASA) regulates 5‐lipoxygenase activity and peroxisome proliferator‐activated receptor α‐mediated CINC‐1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA‐triggered 15‐epi‐LXA4 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] C. Serhan,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Anti-Inflammatory Actions of Lipoxin A 4 Stable Analogs Are Demonstrable in Human Whole Blood: Modulation of Leukocyte Adhesion Molecules and Inhibition of Neutrophil-Endothelial Interactions , 2016 .
[19] J. Wallace,et al. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. , 2002, Gastroenterology.
[20] A. M. Lefer,et al. Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Serhan,et al. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. , 1995, Biochemistry.
[22] C. Clish,et al. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. , 2000, Biochemistry.
[23] O. Levy,et al. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] Carl Nathan,et al. Points of control in inflammation , 2002, Nature.
[25] L. Dong,et al. Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. , 2006, Kidney international.
[26] C. Serhan,et al. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[27] P. Ward,et al. Molecular and Cellular Basis of Inflammation , 1999, Current Inflammation Research.
[28] R. Buerli. Potent hFPRL1 (ALXR) Agonists as Potential Antiinflammatory Agents. , 2006 .
[29] R. Eddy,et al. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. , 1992, Genomics.
[30] F. Martin,et al. Lipoxin, leukotriene, and PDGF receptors cross‐talk to regulate mesangial cell proliferation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] E. Prossnitz,et al. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. , 1992, Biochemical and biophysical research communications.
[32] C. Serhan,et al. Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release , 1998, The Journal of experimental medicine.
[33] P. Ward,et al. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. , 1975, Journal of immunology.
[34] S. Dahlén. Chapter 10 – Lipoxins: Bioactive Lipoxygenase Interaction Products , 1991 .
[35] M. Perretti,et al. Formyl‐peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] A. Spagnolo,et al. Lipoxin A4 Counteracts Synergistic Activation of Human Fibroblast-like Synoviocytes , 2004, International journal of immunopathology and pharmacology.
[37] A. Sher,et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.
[38] T. Takano,et al. A novel rat lipoxin A4 receptor that is conserved in structure and function , 2003, British journal of pharmacology.
[39] K. Matsushima,et al. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. , 1993, International immunology.
[40] J. Baldwin. The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.
[41] D. Gilroy,et al. 15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation , 2004, The Journal of experimental medicine.
[42] C. Serhan. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? , 1997, Prostaglandins.
[43] Eugene Y. Kim,et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.
[44] C. Serhan,et al. Aspirin‐triggered lipoxin A4 and lipoxin A4 up‐regulate transcriptional corepressor NAB1 in human neutrophils , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] B. Spur,et al. The effects of lipoxin A4 on airway responses in asthmatic subjects. , 1992, The American review of respiratory disease.
[46] N. Chiang,et al. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A4 (ATL) , 1999 .
[47] T. Takano,et al. Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor* , 1997, The Journal of Biological Chemistry.
[48] C. Movitz,et al. Ligand recognition and activation of formyl peptide receptors in neutrophils , 2006, Journal of leukocyte biology.
[49] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.
[50] J. Varga,et al. Opposing Regulation of Interleukin-8 and NF-kB Responses by Lipoxin A4 and Serum Amyloid a via the Common Lipoxin a Receptor , 2004, International journal of immunopathology and pharmacology.
[51] C. Serhan,et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Drazen,et al. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. , 1993, The Journal of clinical investigation.
[53] C. Serhan,et al. Identification of a human enterocyte lipoxin a receptor that is regulated by IL-13 and IFN-γ and inhibits TNF-α-induced IL-8 release , 1999 .
[54] M. Freeman,et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. , 1999, The Journal of clinical investigation.
[55] A. Sher,et al. Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection , 2002, The Journal of experimental medicine.
[56] A. Young,et al. Lipoxin A4 Analogs Attenuate Induction of Intestinal Epithelial Proinflammatory Gene Expression and Reduce the Severity of Dextran Sodium Sulfate-Induced Colitis1 , 2002, The Journal of Immunology.
[57] M. Murphy,et al. Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression. , 2000, American journal of physiology. Cell physiology.
[58] B. Spur,et al. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. , 1989, Clinical science.
[59] Ji Ming Wang,et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. McClary,et al. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. , 1992, Gene.
[61] K. Badr,et al. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[62] C. Serhan,et al. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. , 1996, Journal of immunology.
[63] C. Clish,et al. Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators 1 , 2003, The Journal of Immunology.
[64] M. H. Lee,et al. Aspirin-Triggered Lipoxins (15-epi-LX) Are Generated by the Human Lung Adenocarcinoma Cell Line (A549)–Neutrophil Interactions and Are Potent Inhibitors of Cell Proliferation , 1996, Molecular medicine.
[65] F. Luscinskas,et al. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: Dissociation between lipid remodeling and adhesion , 1990, Journal of cellular physiology.
[66] Y. Kaneda,et al. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Varga,et al. Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. , 2000, Biochemistry.
[68] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[69] S. Marullo,et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor , 2002, Nature Medicine.
[70] J. Bousquet,et al. Lipoxins are potential endogenous antiinflammatory mediators in asthma. , 2002, American journal of respiratory and critical care medicine.
[71] E A Dratz,et al. The ligand binding site of the formyl peptide receptor maps in the transmembrane region. , 1997, Journal of immunology.
[72] Jennifer E. Golden,et al. Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. , 2006, Bioorganic & medicinal chemistry letters.
[73] C. Serhan,et al. Lipoxin generation by permeabilized human platelets. , 1992, Biochemistry.
[74] L. Bjeldanes,et al. Lipoxin A4: a new class of ligand for the Ah receptor. , 1999, Biochemistry.
[75] C. Brink,et al. The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues. , 2004, Pharmacology & therapeutics.
[76] C. Serhan,et al. Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking1 , 2000, The Journal of Immunology.
[77] C. Kozak,et al. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. , 1998, Genomics.
[78] J. Kutok,et al. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). , 2002, The Journal of pharmacology and experimental therapeutics.
[79] C. Serhan,et al. Induction of functional lipoxin A4 receptors in HL-60 cells. , 1993, Blood.
[80] A. Sher,et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. , 2005, The Journal of clinical investigation.
[81] C. Serhan,et al. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. , 1998, The Journal of clinical investigation.
[82] C. Serhan,et al. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. , 1992, The Journal of biological chemistry.
[83] I. Akritopoulou‐Zanze,et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.
[84] C. Serhan,et al. Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.
[85] H. Harris. Role of chemotaxis in inflammation. , 1954, Physiological reviews.
[86] U. Francke,et al. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. , 1992, The Journal of biological chemistry.
[87] Hugh R. Brady,et al. Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.
[88] J. Cunningham,et al. N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. , 1993, The Journal of biological chemistry.
[89] M. Brezinski,et al. Lipoxins stimulate prostacyclin generation by human endothelial cells , 1989, FEBS letters.
[90] Takao Shimizu,et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.
[91] C. Clish,et al. Lipoxin A4 and Aspirin-Triggered 15-epi-Lipoxin A4 Inhibit Human Neutrophil Migration: Comparisons Between Synthetic 15 Epimers in Chemotaxis and Transmigration with Microvessel Endothelial Cells and Epithelial Cells 1 , 2003, The Journal of Immunology.
[92] J. Vane. Adventures and excursions in bioassay: the stepping stones to prostacylin , 1983, British journal of pharmacology.
[93] C. Serhan,et al. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[94] C. Serhan,et al. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood. , 1991, Biological mass spectrometry.
[95] A. Sher,et al. Exogenous Pathogen and Plant 15-Lipoxygenase Initiate Endogenous Lipoxin A4 Biosynthesis , 2004, The Journal of experimental medicine.
[96] C. Serhan,et al. Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells 1 , 2003, The Journal of Immunology.
[97] S. Crooke,et al. Lipoxygenases and Their Products , 1991 .
[98] A. Jesaitis,et al. The fate of the N‐formyl‐chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies , 1982, Journal of cellular biochemistry.
[99] K. Nicolaou,et al. Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action. , 1987, Journal of immunology.
[100] A. Fanning,et al. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. , 2000, The Journal of biological chemistry.
[101] B. Spur,et al. Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils. , 1990, Biochemical and biophysical research communications.
[102] M. Arnaout,et al. A synthetic eicosanoid LX‐mimetic unravels host‐donor interactions in allogeneic BMT‐induced GvHD to reveal an early protective role for host neutrophils , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[103] R. Ye,et al. Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. , 2002, Gene.
[104] C. Serhan,et al. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. , 1996, Journal of immunology.
[105] M. Tardif,et al. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. , 1990, Biochemistry.
[106] A. Jesaitis,et al. The N-Formyl Peptide Receptor , 1999 .
[107] D. Haviland,et al. Identification, Cloning, and Functional Characterization of a Murine Lipoxin A4 Receptor Homologue Gene1 , 2002, The Journal of Immunology.
[108] C. Serhan,et al. Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation , 2000, The Journal of experimental medicine.
[109] C. Serhan,et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[110] I. Williams,et al. Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. , 2003, American journal of physiology. Cell physiology.
[111] C. Serhan,et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.
[112] C. Serhan,et al. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A4. , 1999, American journal of physiology. Cell physiology.
[113] J. Vane,et al. Adventures and Excursions in Bioassay: The Stepping Stones to Prostacylin , 1983, Bioscience reports.
[114] F. Boulay,et al. Human mitochondria‐derived N‐formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes‐derived peptides preferentially activate FPR , 2005, European journal of immunology.
[115] Philip M Murphy,et al. Formyl-peptide receptors revisited. , 2002, Trends in immunology.
[116] J. Lindgren,et al. Formation and proliferative effects of lipoxins in human bone marrow. , 1991, Biochemical and biophysical research communications.
[117] Nobelstiftelsen. Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures , 1982 .
[118] C. Clish,et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[119] J. Uddin,et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway , 2004, Nature Immunology.
[120] E. Lycke,et al. Altered kinetic properties of sialyl and galactosyl transferases associated with herpes simplex virus infection of GMK and BHK cells. , 1980, The Journal of general virology.
[121] T. Takano,et al. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.
[122] N. Petasis,et al. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. , 2002, The American journal of pathology.
[123] B. Levy,et al. Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin‐triggered lipoxin A4 , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[124] P. Murphy,et al. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. , 1993, The Journal of biological chemistry.
[125] B. Viviani,et al. CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation , 2006, Respiratory research.
[126] C. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. , 2004, Prostaglandins & other lipid mediators.
[127] N. Petasis,et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. , 2002, Journal of the American Society of Nephrology : JASN.
[128] A. Day,et al. Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils. , 1982, Biochemistry.
[129] J. Johndrow,et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent , 2006, Nature Medicine.
[130] H. Carp. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils , 1982, The Journal of experimental medicine.
[131] S. Zahler,et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.
[132] C. Clish,et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo , 1999 .
[133] J. Varga,et al. Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of Metalloproteinases1 , 2000, The Journal of Immunology.
[134] S. Dahlén,et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.
[135] C. Serhan,et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. , 2001, The American journal of pathology.
[136] J. A. Radding,et al. Further studies on the structural requirements for synthetic peptide chemoattractants. , 1980, Biochemistry.
[137] C. Serhan,et al. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction , 1996, The Journal of experimental medicine.
[138] J. A. Badwey,et al. A Stable Aspirin-Triggered Lipoxin A4 Analog Blocks Phosphorylation of Leukocyte-Specific Protein 1 in Human Neutrophils1 , 2004, The Journal of Immunology.
[139] S. Zigmond,et al. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils , 1976, The Journal of experimental medicine.
[140] M. Perretti,et al. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. , 2003, Blood.
[141] K. Sugamura,et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. , 1999, Journal of immunology.
[142] A. Sher,et al. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity , 2002, Nature Immunology.
[143] B. Levy,et al. Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.